News

• ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics
  03/04/2021 / 22:05 - GlobeNewswire
•  
• Checkpoint Therapeutics to Participate in H.C. Wainwright Global Life Sciences Virtual Conference
  03/04/2021 / 14:00 - GlobeNewswire
•  
• Replimune to Present at Three Upcoming Investor Conferences
  03/04/2021 / 14:00 - GlobeNewswire
•  
• BioXcel Therapeutics to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call and Webcast
  03/04/2021 / 13:00 - GlobeNewswire
•  
• Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
  03/03/2021 / 14:00 - GlobeNewswire
•  
• Purple Biotech Appoints Biopharmaceutical Industry Veteran Robert Gagnon to Board of Directors
  03/03/2021 / 13:00 - GlobeNewswire
•  
• Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
  03/03/2021 / 12:45 - GlobeNewswire
•  
• Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
  03/03/2021 / 12:45 - GlobeNewswire
•  
• Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
  03/02/2021 / 14:30 - GlobeNewswire
•  
• Indeni Joins GitLab Partner Program With Cloud Security Analysis Tool Cloudrail
  03/02/2021 / 14:00 - GlobeNewswire
•  
• Purple Biotech Provides Corporate Update and Reports Second Half and Full Year 2020 Financial Results
  03/02/2021 / 13:00 - GlobeNewswire
•  
• ALX Oncology to Participate at H.C. Wainwright Global Life Sciences Conference
  03/02/2021 / 13:00 - GlobeNewswire
•  
• AzurRx BioPharma to Participate in “Fireside Chat” at the H.C. Wainwright Global Life Sciences Conference
  03/02/2021 / 13:00 - GlobeNewswire
•  
• Highlight & Pivotal start Phase IIa melanoma trial
  03/02/2021 / 12:55 - GlobeNewswire
•  
• ChemoCentryx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
  03/01/2021 / 22:05 - GlobeNewswire